News&Resources

The U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the invalidity of U.S. Patent No. 6,598,603 directed to once-a-day use of nebulized budesonide that covers AstraZeneca’s Pulmicort® Respules product. The opinion affirmed the ruling secured by SSJR in the trial court that the ‘603 patent was […]

SSJR attorneys have secured a decision by the Patent Trial and Appeal Board reversing all rejections in an application related to a surgical insufflation system. Issuance of a patent containing all pending claims is expected in due course.

SSJR attorneys have secured a decision by the Patent Trial and Appeal Board reversing all rejections in an application related to a crankshaft assembly for powering a vehicle accessory. The patent application has been returned to the examiner for further action in accordance with the reversal.

SSJR is pleased to report a successful settlement of a Hatch-Waxman patent infringement case for its clients Lupin Ltd. and Lupin Pharmaceuticals, Inc (“Lupin”). The case was initiated in July 2011 by Alcon Pharmaceuticals Ltd. and Alcon Research, Ltd. (“Alcon”) in the United States District Court for the District of […]

“During the general government shutdown that began October 1, 2013, the United States Patent and Trademark Office will remain open, using prior year reserve fee collections to operate as usual for approximately four weeks. We continue to assess our fee collections compared to our operating requirements to determine how long […]